Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

NCT01354691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Dementia
Memory Loss
Cognitive Impairment

Interventions

DRUG: ladostigil hemitartrate

Sponsor

Avraham Pharmaceuticals Ltd